NCT06098248View on ClinicalTrials.gov

cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

June 30, 2025

Conditions
Benign Brain TumorMalignant Brain Tumor
Interventions
DIAGNOSTIC_TEST

cCeLL - Ex vivo

Neoplastic brain tissue biopsied from participant will be visualized, and images will be captured using cCeLL - Ex vivo.

Trial Locations (4)

M5B 1W8

St. Michael's Hospital, Toronto

Unknown

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Unity Health Toronto

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Seoul National University Hospital

OTHER

lead

VPIX Medical

INDUSTRY

NCT06098248 - cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis | Biotech Hunter | Biotech Hunter